Evidence map›Paper›PMID 40595356›Full record

ArticleBone marrow transplantation2025

Nabiximols oromucosal spray in patients with chronic graft-versus-host disease: effects on sclerodermatous features and refractory muscle cramps.

Rodrigo Gil-Manso, Cristina Hidalgo Calleja, Laura Puebla Tornero, Almudena Cabero-Martínez, Ana García-Bacelar, Ana África Martín López, Mónica Cabrero, Mónica Baile, Estefanía Pérez-López, Alejandro Avendaño Pita and 5 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rodrigo Gil-MansoHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain. rodrigogm2812@gmail.com.ORCID http://orcid.org/0000-0003-2093-7119
Cristina Hidalgo CallejaReumatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain.
Laura Puebla TorneroDermatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain.
Almudena Cabero-MartínezHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
Ana García-BacelarHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
Ana África Martín LópezHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
Mónica CabreroHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.ORCID http://orcid.org/0000-0001-7586-4792
Mónica BaileHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
Estefanía Pérez-LópezHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
Alejandro Avendaño PitaHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
Lourdes Vázquez LópezHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
Jennifer Alonso RodríguezHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
María Del Carmen Gilabert GutiérrezHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
Fermín Sánchez-GuijoHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain.
Lucía López-CorralHematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Departamento de Medicina, Universidad de Salamanca, Centro de Investigación del Cáncer-IBMCC, CIBERONC, Salamanca, Spain. lucialopezcorral@usal.es.ORCID http://orcid.org/0000-0003-1908-5596

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40595356

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.